Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Anne Quinquenel Loïc Ysebaert |
| Publication date | December 4, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |